home / stock / cyad / cyad news


CYAD News and Press, Celyad SA From 12/15/21

Stock Information

Company Name: Celyad SA
Stock Symbol: CYAD
Market: NASDAQ

Menu

CYAD CYAD Quote CYAD Short CYAD News CYAD Articles CYAD Message Board
Get CYAD Alerts

News, Short Squeeze, Breakout and More Instantly...

CYAD - Celyad Oncology (CYAD) Presents 2021 American Society of Hematology Meeting Update - Slideshow

The following slide deck was published by Celyad Oncology SA in conjunction with this event. For further details see: Celyad Oncology (CYAD) Presents 2021 American Society of Hematology Meeting Update - Slideshow

CYAD - Transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that it has rece...

CYAD - Celyad Oncology presents updates on shRNA-based CAR T programs at ASH meeting

Celyad Oncology (NASDAQ:CYAD) announces that data from the Phase 1 CYCLE-1 trial of CYAD-02 for the treatment of relapsed or refractory (r/r) acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) and the Phase 1 IMMUNICY-1 trial of CYAD-211 for the treatment of r/r multiple myeloma...

CYAD - Celyad Oncology Presents Updates on shRNA-Based CAR T Programs at the 63rd ASH Annual Meeting and Exposition

Data continues to support the versatile potential of non-gene edited shRNA technology with updates from the CYAD-02 and CYAD-211 clinical programs Management to host conference call today December 13th at 2:30 p.m. CET / 8:30 a.m. EST MONT-SAINT-GUIBERT, Belgium, Dec. 13...

CYAD - Celyad Oncology Announces Closing of $32.5 Million Private Placement with Fortress Investment Group Affiliate

MONT-SAINT-GUIBERT, Belgium, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext & Nasdaq: CYAD) (“Celyad” or the “Company”), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T...

CYAD - Novavax among healthcare gainers; HealthEquity and VYNE Therapeutics among losers

Gainers: Elevation Oncology (NASDAQ:ELEV) +25%. BeyondSpring (NASDAQ:BYSI) +21%. Nemaura Medical (NASDAQ:NMRD) +18%. Regencell Bioscience Holdings (NASDAQ:RGC) +17%. Novavax (NASDAQ:NVAX) +17%. Losers: HealthEquity (NASDAQ:HQY) -23%. Cumberland Pharmaceuticals (NASDAQ:CPIX) -21%. VY...

CYAD - How to Make Money With Penny Stocks And the Omicron Variant

3 Tips to Making Money With Penny Stocks Considering the New Variant With the Omicron variant in full swing, those who invest in penny stocks are continuously looking for the best small caps to buy. But, to have the best chance at making money with penny stocks in 2021 , investors n...

CYAD - CAN, CTIC and DNUT among mid-day movers

Gainers: Celyad (NASDAQ:CYAD) +35%. Longeveron (NASDAQ:LGVN) +29%. Marvell Technology (NASDAQ:MRVL) +18%. Petros Pharmaceuticals (NASDAQ:PTPI) +17%. CTI BioPharma (NASDAQ:CTIC) +16%. Tilly's (NYSE:TLYS) +14%. Krispy Kreme (NASDAQ:DNUT) +10%. PetIQ (NASDAQ:PETQ) +9%. Vicinity (NASDAQ:VEV) +9%....

CYAD - SWBI Stock: Why Smith & Wesson Shares Are Getting Gunned Down Today

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Smith & Wesson (NASDAQ: SWBI ) stock is feeling the heat on Friday following the release of its fiscal second-quarter 2022 earnings report. Source: Supakorn Pe / Shutterstock.com Starting off the bad news ...

CYAD - Hot Biotech Stocks: Why Celyad Oncology (CYAD) Is Soaring Higher Today

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Celyad Oncology (NASDAQ: CYAD ) stock is heading higher on Friday thanks to some recent news. Source: Kevin McGovern / Shutterstock.com The big announcement sending CYAD stock higher today is a $32.5 million ...

Previous 10 Next 10